Journal of Nanomedicine & Nanotechnology

Onkar S. Vaze

Onkar S. Vaze
Formulation Scientist, PTC Therapeutics Inc.
New Jersey, USA

Biography

Dr.Vaze is a Formulation Scientist at PTC Therapeutics, Inc., New Jersey, USA. He attended Northeastern University, Boston, MA where in 2012 he received a PhD in Pharmaceutical Sciences with specialization in Pharmaceutics and Drug Delivery systems. Doctoral dissertation involved development of a lipid-based delivery system for a small molecule drug, using pharmaceutical nanocarriers to specifically target and inhibit cancer cell multiplication in vitro and in vivo and development of a lipid-based system for effective stabilization and enhanced delivery of small interfering RNAs (siRNA). Dr.Vaze has co-authored research papers and a book chapter in high impact scientific international peer reviewed journals. He has more than seven years of academic/industrial experience designing, planning, and conducting comprehensive research, analysis, and experimentation to drive the development of new drug formulations. He has experience in preformulation studies, preclinical formulations and formulation development of small and large molecules and has a strong understanding of US-FDA guidelines. He has also served as a reviewer for high impact peer reviewed scientific journals

Research Interest

• Preformulation, preclinical formulations and Formulation development (small and large molecules like small interfering RNAs)
• Nanocarriers (liposomes, micelles, nanoparticles) • Pharmaceutics and Drug Delivery
• SMEDDS and SEDDS
• Solid Dosage form: Tablets, capsules, Drug excipient compatibility, Design of experiments, Quality by design
• Pharmaceutical Technologies: Amorphous dispersions, Hot melt extrusion